Status:
COMPLETED
Minimizing Fall-Related Injury in Older Adults: a Motor Learning Approach
Lead Sponsor:
University of Kansas Medical Center
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Fall Injury
Fall Patients
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Falls are the leading cause of accidental injury and injury-related death among older adults. Despite evidence that falls can be prevented, fall related injuries have not declined over time. Current f...
Detailed Description
Impact forces and body accelerations can be mitigated by performing specific movement patterns during the impact phase of a fall. The investigators, along with others have postulated and provided prel...
Eligibility Criteria
Inclusion
- Have balance impairment as indicated by \<10s on unipedal stance
- History of fall injury in the last year; or, two more falls in the last year; or, afraid of falling because of problems with balance or walking
- Have no history of tumbling, gymnastic or martial art experience or currently engagement of 150+ minutes/week of vigorour aerobic activity
- No clinical osteoporosis
- DEXA (dual energy X-ray absorptiometry) determined bone mineral density of the hip of t is greater than or equal to -2.3
Exclusion
- Outside of age range
- Unable to speak or comprehend written/spoken English
- Cognitive impairment as indicated by Saint Louis University Memory Scale (\<25)
- Unable to ambulate household distances
- Intact standing balance as indicated by \>10s of unipedal stance
- Currently receiving physical therapy
- Presence of clinical osteoporosis
- Uncorrected vision or hearing or vestibular dysfunction
- Major neurological conditions, such as stroke, Parkinson's Disease, vertigo that affect the ability to ambulate or perform daily tasks
- Currently taking medications, including, coumadin, dual oral anticoagulants (apixaban, rivaroxaban), lovenox
- Conditions may lead to (internal) bleeding, such as thrombocytopenia, hemorrhagic diathesis
Key Trial Info
Start Date :
July 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 5 2024
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT05260034
Start Date
July 18 2022
End Date
April 5 2024
Last Update
November 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emma Eells
Kansas City, Kansas, United States, 66103